Develop

IVI’s clinical capacities and activities include assessing vaccine safety and efficacy, collaborating with partners worldwide to plan and implement Phase 1-4 clinical trials, and providing training and clinical assistance to ensure all trials adhere to international standards and principles of Good Clinical Practice.

We help manufacturers and sponsors of new vaccines navigate the path to national regulatory approvals, from preparing Investigational New Drug applications to facility inspections.

One of our key objectives with new vaccines is supporting manufacturers in reaching World Health Organization prequalification, enabling public agencies to procure the vaccines for global health use.